Efficacy of Scalp Cooling System Versus Chemical Cooling Cap in Preventing Chemotherapy-Induced Alopecia in Breast Cancer: A Prospective Randomized Trial

    April 2026 in “ The Breast
    Jie Zhang, Lize Wang, Yingjian He, Hongjuan Sun, Jiaxiaopan Niu, Mengcai Duan, Chao Miao, Jinfeng Li, Wei Cao, Xing Wang, Xinguang Wang, Yang Yang, Zhaoqing Fan, Xinying Yu
    TLDR Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.
    The COHAIR study, a prospective randomized trial, compared the efficacy of a scalp cooling system and a chemical cooling cap in preventing chemotherapy-induced alopecia (CIA) in 152 breast cancer patients. Results showed that hair preservation success rates were 74.5% for the scalp cooling system and 71.2% for the chemical cooling cap, with both methods demonstrating good tolerability. While scalp cooling was more effective during early anthracycline treatment, the chemical cooling cap resulted in lower anxiety scores and better quality of life (QoL). Disease-free survival was similar between the two groups.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results